Clinical Trials in Nashville

Showing 17241-17260 of 20,298 trials

AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy

NCT00372944

The purpose of this study is to assess the efficacy and safety of AZD6244 (ARRY-142886)versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line therapy with gemcitabine. Following baseline assessments, a minimum of 64 patients in approximately 5-6 centers from the US will be treated with either AZD6244 or capecitabine. Treatment will be continued for as long as the patients receive clinical benefit. The status of all patients will be checked (whether they are still taking treatment or not) approximately 3 months after the last patient has entered the study.

Pancreatic Cancer

AstraZeneca70 participantsStarted Aug 2006

Alhambra, California, United States • Bakersfield, California, United States • Palm Springs, California, United States +14 more locations

COMPLETEDPhase 2< 1 mile

AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen

NCT00372788

The purpose of this study is to assess the effect and safety of AZD6244(ARRY-142886)versus pemetrexed in the second or third line treatment of advanced Non-Small Cell Lung Cancer. Following baseline assessments, a minimum of 64 patients in approximately 5-6 centers from the US will be treated with either AZD6244 or pemetrexed. Treatment will be continued for as long as patients receive clinical benefit.

Non-small Cell Lung Cancer

AstraZeneca88 participantsStarted Aug 2006

Los Angeles, California, United States • Ann Arbor, Michigan, United States • New York, New York, United States +5 more locations

AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy

AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen

Find Trials by Condition in Nashville

Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia

Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose

A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis

Study of Silodosin to Facilitate Passage of Urinary Stones

A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)

A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma

The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence

Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery

Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

The CareFUL Prevention Trial

A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction